336
Views
4
CrossRef citations to date
0
Altmetric
Review

Cardiovascular remodeling in obstructive sleep apnea: focus on arterial stiffness, left ventricular geometry and atrial fibrillation

, , , ORCID Icon &
Pages 455-464 | Received 22 Dec 2021, Accepted 20 May 2022, Published online: 08 Jun 2022

References

  • Linz D, Woehrle H, Bitter T, et al. The importance of sleep-disordered breathing in cardiovascular disease. Clin Res Cardiol. 2015;104(9):705–718.
  • Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687–698.
  • Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021 Jul 20;144(3):e56–e67.
  • Berry RB, Budhiraja R, Gottlieb DJ, et al. American Academy of Sleep Medicine. rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events: deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597–619.
  • Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479–504.
  • Hindricks G, Potpara T, Dagres N, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.
  • Chen X, Wang R, Zee P, et al. Racial/ethnic differences in sleep disturbances: the Multi-Ethnic Study of atherosclerosis (Mesa). Sleep. 2015;38(6):877–888.
  • Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–1014.
  • Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69(7):841–858.
  • Nadeem R, Singh M, Nida Met al, Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med. 2014;10(5):475e89
  • Martínez-Cerón E, Casitas R, Galera Ret al, Contribution of sleep characteristics to the association between obstructive sleep apnea and dyslipidemia. Sleep Med. 2021;84:63–72.
  • Peter-Derex L, Derex L. Wake-up stroke: from pathophysiology to management. Sleep Med Rev. 2019;48:e101212.
  • Williams B, Mancia G, Spiering W, et al. ESC/ESH Guidelines for the management of arterial hypertension. the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension. J Hypertens. 2018;36:1953–2041.
  • Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in Adults: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e484–e594. 2017.
  • O’Brien E, Parati G, Stergiou G, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–1768.
  • Hoshide S, Kario K, Chia YC, et al. An Asian experience. J Clin Hypertens (Greenwich). 2021;23(3):489–495.
  • Cuspidi C, Tadic M, Gherbesi E, et al. Targeting subclinical organ damage in obstructive sleep apnea: a narrative review. J Hum Hypertens. 2021;35(1):26–36.
  • Kario K, Kanegae H, Tomitani N, et al. Nighttime blood pressure measured by home blood pressure monitoring as an independent predictor of cardiovascular events in general practice. Hypertension. 2019;73(6):1240–1248.
  • Di Raimondo D, Musiari G, Pinto A. Nocturnal blood pressure patterns and cardiac damage: there is still much to learn. Hypertens Res. 2020;43(3):246–248.
  • Tveit RL, Lehmann S, Bjorvatn B. Prevalence of several somatic diseases depends on the presence and severity of obstructive sleep apnea. PLoS One. 2018 Feb 23;13(2):e0192671.
  • Xie C, Zhu R, Tian Y, et al. Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis. BMJ Open. 2017;7(12):e013983.
  • Cuspidi C, Tadic M, Sala C, et al. Targeting concentric left ventricular hypertrophy in obstructive sleep apnea syndrome. A meta-analysis of echocardiographic studies. Am J Hypertens. 2020;33(4):310–315.
  • Cuspidi C, Tadic M, Sala Cet al, Obstructive sleep apnoea syndrome and left ventricular hypertrophy: a metaanalysis of echocardiographic studies. J Hypertens. 2020;38:1640–1649.
  • Wang D, Xu JZ, Kang YY, et al. Aortic Root Diameter in Hypertensive patients with various stages of obstructive sleep apnea. Am J Hypertens. 2022;35(2):142–148.
  • Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure. Sleep Heart Health Study Circulation. 2010;122(4):352–360.
  • Roca GQ, Redline S, Claggett B, et al. Sex-specific association of sleep apnea severity with subclinical myocardial injury, ventricular hypertrophy, and heart failure risk in a community-dwelling cohort: the Atherosclerosis Risk in Communities–Sleep Heart Health Study. Circulation. 2015;132(14):1329–1337.
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.
  • Saeed S, Romarheim A, Mancia G, et al. Characteristics of hypertension and arterial stiffness in obstructive sleep apnea: a Scandinavian experience from a prospective study of 6408 normotensive and hypertensive patients. J Clin Hypertens (Greenwich). 2022;24(4):385–394.
  • Johnson DA, Thomas SJ, Abdalla M, et al. Association between sleep apnea and blood pressure control among blacks. Circulation. 2019 Mar 5 139(10):1275–1284.
  • Saeed S, Waje-Andreassen U, Nilsson PM. The Association of the Metabolic Syndrome with Target Organ Damage: Focus on the Heart, Brain and Central Arteries. Expert Rev Cardiovasc Ther. 2020;18:601–614.
  • Drager LF, Bortolotto LA, Figueiredo AC, et al. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131(5):1379–1386.
  • Jenner R, Fatureto-Borges F, Costa-Hong V, et al. Association of obstructive sleep apnea with arterial stiffness and nondipping blood pressure in patients with hypertension. J Clin Hypertens. 2017;19(9):910–918.
  • Kim J, Lee SK, Yoon DW, et al. Obstructive sleep apnoea is associated with progression of arterial stiffness independent of obesity in participants without hypertension: a KoGES Prospective Cohort Study. Sci Rep. 2018;8(1):8152.
  • Song F, Zou J, Song Z, et al. Association of adipocytokines with carotid intima media thickness and arterial stiffness in obstructive sleep apnea patients. Front Endocrinol. 2020;11:177.
  • Joyeux-Faure M, Tamisier R, Borel JC, et al. Contribution of obstructive sleep apnoea to arterial stiffness: a meta-analysis using individual patient data. Thorax. 2018;73(12):1146–1151.
  • Kwon Y, Logan J, Redline S, et al. Obstructive sleep apnea and structural/functional properties of the thoracic ascending aorta: the Multi-Ethnic Study of Atherosclerosis (Mesa). Cardiology. 2019;142(3):180–188.
  • Kim T, Lee CS, Lee SD, et al. Impacts of comorbidities on the association between arterial stiffness and obstructive sleep apnea in the elderly. Respiration. 2015;89(4):304–311.
  • Galerneau LM, Bailly S, Borel JC, et al. Long-term variations of arterial stiffness in patients with obesity and obstructive sleep apnea treated with continuous positive airway pressure. PLoS One. 2020 Aug 5;15(8):e0236667.
  • Mancia G, Fagard R, Narkiewicz K, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–1357.
  • Traaen GM, Øverland B, Aakerøy L, et al. Prevalence, risk factors, and type of sleep apnea in patients with paroxysmal atrial fibrillation. IJC Heart Vasculature. 2020 Feb;26:100447.
  • Linz D, Nattel S, Kalman JM, et al. Sleep Apnea and Atrial Fibrillation. Card Electrophysiol Clin. 2021;13(1):87–94.
  • Tanigawa T, Yamagishi K, Sakurai S, et al. Arterial oxygen desaturation during sleep and atrial fibrillation. Heart. 2006;92:1854–1855.
  • Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. collaboration with the National Heart. Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080–1111.
  • Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364–367.
  • Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49(5):565–571.
  • Marti-Almor J, Marques P, Jesel L, et al. Incidence of sleep apnea and association with atrial fibrillation in an unselected pacemaker population: results of the observational RESPIRE study. Heart Rhythm. 2020 Feb;17(2):195–202.
  • Goudis CA, Ketikoglou DG. Obstructive sleep and atrial fibrillation: pathophysiological mechanisms and therapeutic implications. Int J Cardiol. 201;230:293–300.
  • Linz D, McEvoy RD, Cowie MR, et al. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a Review. JAMA Cardiol. 2018;3(6):532–540.
  • Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003 May 27;107(20):2589–2594.
  • Anter E, Di Biase L, Contreras-Valdes FM, et al. Atrial substrate and triggers of paroxysmal atrial fibrillation in patients with obstructive sleep apnea. Circ Arrhythm Electrophysiol. 2017 Nov;10(11):e005407.
  • Ng CY, Liu T, Shehata M, et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108(1):47–51.
  • Monahan K, Brewster J, Wang L, et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2012;110(3):369–372.
  • Gami AS, Olson EJ, Shen WK, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol. 2013;62(7):610–616.
  • Zota IM, Stătescu C, Sascău RA, et al. Arterial Stiffness assessment using the arteriograph in patients with moderate-severe OSA and metabolic syndrome-A pilot study. J Clin Med. 2021;10(18):4238.
  • Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007 Apr 23;167(8):757–764.
  • Magalang UJ, Richards K, McCarthy B, et al. Continuous positive airway pressure therapy reduces right ventricular volume in patients with obstructive sleep apnea: a cardiovascular magnetic resonance study. J Clin Sleep Med. 2009;5(2):110–114.
  • Colish J, Walker JR, Elmayergi N, et al. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest. 2012;141(3):674–681.
  • Xu L, Keenan BT, Maislin D, et al. Effect of obstructive sleep apnea and positive airway pressure therapy on cardiac remodeling as assessed by cardiac biomarker and magnetic resonance imaging in nonobese and obese adults. Hypertension. 2021;77(3):980–992.
  • McEvoy RD, Antic NA, Heeley E, et al. SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919–931.
  • Mazzotti DR, Keenan BT, Lim DC, et al. Symptom subtypes of obstructive sleep apnea predict incidence of cardiovascular outcomes. Am J Respir Crit Care Med. 2019;200(4):493–506.
  • Javaheri S, Martinez-Garcia MA, Campos-Rodriguez F, et al. Continuous positive airway pressure adherence for prevention of major adverse cerebrovascular and cardiovascular events in obstructive sleep apnea. Am J Respir Crit Care Med. 2020;201(5):607–610.
  • Patel N, Donahue C, Shenoy A, et al. Obstructive sleep apnea and arrhythmia: a systemic review. Int J Cardiol. 2017;228:967–970.
  • Holmqvist F, Guan N, Zhu Z, et al. ORBIT-AF Investigators. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015;169(5):647–654.e2.
  • Neeland IJ, Eliasson B, Kasai T, et al. EMPA-REG OUTCOME Investigators. The Impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME Trial. Diabetes Care. 2020;43(12):3007–3015.
  • Pelaia C, Armentaro G, Miceli S, et al. Association between sleep apnea and valvular heart diseases. Front Med (Lausanne). 2021 Aug 9;8:667522.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.